KANGSTEM BIOTECH CO., LTD. financial statements, including revenue, expenses, and profit
The total revenue of 217730 for the last quarter is 3.27 B KRW, and it's 317.17% higher compared to the previous quarter. The net income of Q4 24 is -7.66 B KRW.